Interface Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Interface Biologics's estimated annual revenue is currently $1.4M per year.
- Interface Biologics's estimated revenue per employee is $155,000
Employee Data
- Interface Biologics has 9 Employees.
- Interface Biologics grew their employee count by -31% last year.
Interface Biologics's People
| Name | Title | Email/Phone |
|---|
Interface Biologics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Interface Biologics?
Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI's primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.Â
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Interface Biologics News
Global Electrophysiology Laboratory Devices Market 2022 Industry Growth Abbott, Cardiorobotics, Interface Biologics, Meridian Health System.
Alere; Cardiorobotics; Interface Biologics; Meridian Health System; Cardiva Medical; Lombard Medical Technologies; Deltex Medical Group; Biotelemetry; Bioheart...
Alere Inc., Cardiorobotics Inc., Interface Biologics Inc., Meridian Health System Inc, Cardiva Medical Inc., Lombard Medical Technologies...
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 9 | 13% | $53M |
#2 | $0.9M | 9 | -18% | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.1M | 9 | -18% | $1.3M |
#5 | $0.7M | 9 | N/A | N/A |